Copertina

Matrix‐Free Afterglow Carbon Dots: Synthetic Strategies, Luminescence Mechanisms, and Emerging Applications

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yupeng Liu, Xiangxin Sun, Zhiqi Cai, Hanyi Zhang, Yiming Hao, Songnan Qu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Carbon Innovation
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

S‐Doped Carbon Nitride Thin Films From a Triazole Precursor
di: Yen‐Han Wang, et al.
Pubblicazione: (2026)

Mass Transport Mechanisms in 2D Laminar Nanofluidic Membranes for Separation and Energy Conversion
di: Adhy Prihatmiko Wibowo, et al.
Pubblicazione: (2026)

Establishing a Model Precursor System: Over a Decade of Research on Carbon Dots from the Citric Acid‐Urea System
di: Yupeng Liu, et al.
Pubblicazione: (2026)

Inter‐Verified Binary Classification Models: Unveiling Key Polymer Features Against Staphylococcus aureus
di: Jooyoung Roh, et al.
Pubblicazione: (2026)

Recent Advances in Highly Luminescent Carbon Dots
di: Yupeng Liu, et al.
Pubblicazione: (2024)

AI and Big Data in Oncology: A Physician‐Centered Perspective on Emerging Clinical and Research Applications
di: Binliang Liu, et al.
Pubblicazione: (2026)

Albuquerque's Free-Wheeling Library
di: Waugh, Lynne, et al.
Pubblicazione: (1971)

Triple Matrix Confinement‐Induced Ultrabright Afterglow From Carbon Dots With Multivariate Responsive Afterglow Colors for Advanced Dynamic Information Encryption
di: Yupeng Liu, et al.
Pubblicazione: (2026)

Triple Matrix Confinement‐Induced Ultrabright Afterglow From Carbon Dots With Multivariate Responsive Afterglow Colors for Advanced Dynamic Information Encryption
di: Yupeng Liu, et al.
Pubblicazione: (2026)

Rationale and Trial Design of DAWNA‐FES Trial: Single‐Arm Phase II Study of Endocrine Therapy With Dalpiciclib After Progression on CDK4/6 Inhibition Based on [ 18 F]FES PET/CT in Patients With HR+/HER2− Advanced Breast Cancer
di: Ru Yao, et al.
Pubblicazione: (2026)

Investigating the Mechanism of IFN‐γ‐Inducible Lysosomal Thiol Reductase‐Mediated Inhibition of Breast Cancer Cell Proliferation
di: Qin Liu, et al.
Pubblicazione: (2025)

The Disruptor's Dilemma: Exploring the Dynamic Optimal Distinctiveness Mechanisms of Disruptive New Entrants in Value Co‐Creation
di: Yanjuan Li, et al.
Pubblicazione: (2025)

Combining Small‐Molecular Compounds With CAR T‐Cell Therapy: Novel Strategies for Enhanced Cancer Immunotherapy
di: Rangzi Yi, et al.
Pubblicazione: (2026)

‘Good Enough’: The Use of Satisficing in the Design of Disruptive Innovation in Emerging Economies
di: Jie Xue, et al.
Pubblicazione: (2025)

Inetetamab combined with sirolimus and chemotherapy for the treatment of HER2‐positive metastatic breast cancer patients with abnormal activation of the PI3K/Akt/mTOR pathway after trastuzumab treatment
di: Qiao Li, et al.
Pubblicazione: (2024)

In‐Depth Analysis of the Necessity and Optimization Strategies for Adjuvant Radiotherapy Following Neoadjuvant Immunotherapy in the New Era of Esophageal Cancer Treatment
di: Guohui Liu, et al.
Pubblicazione: (2025)

Global, Regional, and National Burden of Breast Cancer in Adolescents and Young Adults Aged 15–39 Years From 1990 to 2021 Based on the Global Burden of Disease Study 2021
di: Zheng Qu, et al.
Pubblicazione: (2025)

After the Hype: Resilience Seeking in Emerging Technology Ecosystems
di: Fiona Schweitzer, et al.
Pubblicazione: (2026)

Territorial Standards for Innovation: Analysis for the Regions of Portugal
di: Manuela Natário
Pubblicazione: (2012)

Epi‐Immunotherapy in Cancer Treatment: Mechanisms, Clinical Progress, and Future Directions
di: Nannan Lu, et al.
Pubblicazione: (2025)

Role of liquid–liquid phase separation in cancer: Mechanisms and therapeutic implications
di: Xuesong Li, et al.
Pubblicazione: (2024)

An Anoikis Resistance Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Blockades in Gastric Cancer
di: Xing Cai, et al.
Pubblicazione: (2026)

Binary and Ternary Classification Prediction for Breast Cancer and Breast Sclerosing Adenosis With Interpretable Artificial Intelligence From Clinical and Imaging Features: A Retrospective, Diagnostic Accuracy Cohort Study
di: Yang Qu, et al.
Pubblicazione: (2026)

INOVATION MANAGEMENT AND VALUE CHAIN DESIGN: CASE OF A SMALL PROFESSIONAL SERVICES FIRM
di: Haven Allahar
Pubblicazione: (2019)

Histone deacetylase 6 as a novel promising target to treat cardiovascular disease
di: Ya‐Xi Wu, et al.
Pubblicazione: (2024)

Deciphering the Chemotherapeutic Mechanism of Ferulic Acid: Insight Into the Role Against Multiple Human Cancers
di: Sanzida Khatun, et al.
Pubblicazione: (2026)

Profiting From Frugal Innovation: A Strategy‐Tripod‐View and Evidence From China
di: Tanveer Ahmed Mangi, et al.
Pubblicazione: (2025)

Technological Strategies in Brazil’s Manufacturing Industry: A Study Based on Innovative Activities
di: Enéas Gonçalves de Carvalho
Pubblicazione: (2021)

The missing Link in workplace happiness
di: Illarionova, Natalia
Pubblicazione: (2026)

Extrachromosomal Circular DNA as a Cancer Biomarker: From Diagnosis to Treatment
di: Hexin Li, et al.
Pubblicazione: (2025)

Critical Aspects of the Innovation Management: the cases Natura and Oxiteno
di: Sheila Serafim da Silva
Pubblicazione: (2017)

La compra pública de innovación. Instrumento de colaboración para nuevos escenarios
di: Maspons, Ramon, et al.
Pubblicazione: (2018)

BRIDGING INNOVATION AND ENTERPRISE: A FRAMEWORK FOR SUSTAINABLE BUSINESS PERFORMANCE
di: Okonkwo, Chidinma Ebere
Pubblicazione: (2025)

A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021
di: Hong Zhao, et al.
Pubblicazione: (2025)

Multifaceted roles and functions of SOX30 in human cancer
di: Na Sun, et al.
Pubblicazione: (2024)

Consensus on Human Epidermal Growth Factor Receptor 2 Overexpression Testing in Pan‐Tumor
di: Zhe Wang, et al.
Pubblicazione: (2026)

The Impact of Emerging Technologies on Business Management Innovation and Competitive Advantage
di: Candy R. Galapon, et al.
Pubblicazione: (2025)

Innovation for Sufficiency: How Businesses Support a Disruptive Consumption Strategy
di: Indra da Silva Wagner, et al.
Pubblicazione: (2026)

The evolution of the local innovation agents (ALI) program methodology and its contribution to the innovation management at Medicatriz Dermocosmetics
di: Lívia Luize Marengo
Pubblicazione: (2022)

R&D investment and the arrangement of innovation capabilities in Brazilian manufacturing firms
di: Estêvão Passuello Ruffoni
Pubblicazione: (2018)